• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma, Inc. - Common Stock (NQ:SILO)

    5.260 -0.020 (-0.38%)
    Streaming Delayed Price Updated: 2:01 PM EDT, Jul 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Silo Pharma, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Subsidiary QwikAgents Joins AMD AI Developer Program
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
    Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session. ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    The market is filled with gapping stocks in Friday's session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Friday. ↗
    Via Chartmill
    News headline image
    Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Discover the top movers in Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
    NVIDIA developer program resources expected to support autonomous AI agent innovation and marketing 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
    Via Investor Brand Network
    News headline image
    Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Launches Ibogaine-Based TBI Therapeutics Initiative
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
    From Silo Pharma, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Highlights Federal Momentum Advancing Psychedelic Therapeutics Development
    Via Investor Brand Network
    News headline image
    Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Top movers in Thursday's session ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
    From Silo Pharma, Inc.
    Via GlobeNewswire
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    Which stocks are most active on Tuesday? ↗
    Via Chartmill
    On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    Gapping stocks in Tuesday's session ↗
    Via Chartmill
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances IP Portfolio With EPO Notice of Intent to Grant Patent
    Via Investor Brand Network
    Topics Intellectual Property
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.